cell
TH17 Cell
Barrier helper state that recruits neutrophils and protects against extracellular bacteria and fungi
Review layer
Last reviewed 2026-05-17
Systems teaching draft. Content is structured for education and graph expansion, with formal source tagging ready for the next review pass.
State signature
Systems profile
Graph neighborhood
Direct relationships
IL-6, TGF-beta, and IL-1beta support TH17 differentiation
TH17 cells coordinate IL-17-rich mucocutaneous barrier defense and neutrophil recruitment
Network behavior
Systems Overview
TH17 cells produce IL-17-family signals that drive epithelial chemokines, neutrophil recruitment, antimicrobial peptides, and barrier inflammation.
Lineage
Origin
Naive CD4 T cell -> IL-6/TGF-beta/IL-1beta priming -> RORγt-positive TH17 cell
Transcription factors: RORγt, STAT3, BATF, IRF4
Lifecycle Visualizer
days
Barrier priming
RORγt induction
days-weeks
Stabilization
Pathogenic or protective TH17
days-weeks
Effector loop
Epithelial chemokine induction
weeks-months
Resolution or persistence
Treg/SCFA control or chronic barrier inflammation
Activation and Suppression
Surface and Secreted Signals
Metabolic State
Programs
Acute: Epithelial IL-17 response increases CXCL8-like chemokines and neutrophil recruitment.
Chronic: Persistent TH17 tone can sustain psoriasis-like, gut, joint, and autoimmune inflammation.
Tissue Roles
gut: Microbiome-linked barrier defense and inflammatory bowel risk.
lung: Neutrophilic airway inflammation and fungal defense.
skin: Psoriasis-like keratinocyte activation and antimicrobial peptide programs.
lymphoid: Can be reinforced by IL-23-rich dendritic cell programs.
Disease Associations
Clinical Pearls
- TH17 connects microbiome ecology to neutrophil-heavy barrier inflammation.
- IL-23 often stabilizes chronic pathogenic TH17 behavior.
- TH17 is not simply bad; it is essential for fungal and extracellular bacterial defense.